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Abstract  
The Histologic studies on the spleen was carried out with Chloroquine, Fansidar, Cotecxin and Amalar to 
observe any pathologic effect(s) on the tissue on comparative basis. The study revealed some degenerated white 
pulps and wider interstitial spaces with chloroquine drug not observed in control samples. Also animals with 
fansidar administration showed clumping of periateriolar lymphoid cells in the white pulp not shown in the 
control group without any drug. In the Amalar group the spleen showed sinuisoidal dilation in the red pulp with 
macrophages scattered around it but not in the form of activation. For cotecxin drug there was the degeneration 
of periarteriolar lymphoid sheaths with residue of the infiltrated cells in the arterioles. It is concluded that 
chloroquine, fansidar, cotecxin may induce jaundice and splenic disorders. 
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INTRODUCTION  
 The spleen is the largest lymph gland in the body formed by the combination of reticular and lymphatic 
tissue. It is positioned in the left hypochondriac region of the abdominal cavity but located between the fundus of 
the stomach and the diaphragm. It is oval in shape and enclosed in a fibroblastic capsule, Waugh and grant 
(2001). The physiologic functions of the spleen rest in the pulp: the red and the white pulp. The spleen is very 
central in the metabolic function of the liver e.g. bilirubin by being the conduit of passage of its product 
including others from the aged and abnormal erythrocytes destruction, the spleen also serves as organ of such 
destruction.  
 But very vital in its body defense functions is that of phagocytosis of foreign particles of bacteria, 
viruses, malaria parasite etc. However, such phagocytic function affects leucocytes and the platelets which 
perhaps are often those obsolete for body function.  
 But in hemorrhagic situation, the spleen feeds the circulation with augmented volume of blood. The 
spleen is also erythropoietic organ as it serves as source of fetus blood formation Guyton, 2006, Hoffbrand 1991 
and presence of T. & B. lymphocytes also confirm the immunologic properties of this organ. 
 However, in infection like malaria the spleen is enlarged (splenomegaly). Such enlargement may lead to 
splenic pooling of the erythrocytes which may result in anemia. Even in asymptomatic malaria splenomegaly is 
highly prevalence, Franca, 2005. Also in endemic condition of schistosomiasis and leishmaniasis there abound 
also splenomegaly. Splenomegaly is very common in tropical West Africa mainly due to malaria, splenomegaly 
is said to raise Igm levels with hepatic sinusoidal lymphatic, Bates, (1992). Organs tolerated antimalaria drugs 
need be utilized in malaria treatment as confirmed in spleen reduction with particular antimalaria and not others, 
Fakunla, (1981). Non tolerated antimalaria by the spleen mean negative effects on the spleen. Based on this, a 
review of some old and some new antimalaria drugs as per the possible negative effects on the spleen was done. 
The aim being the advocacy for continuous revalidation and evaluation of antimalaria drugs based on the 
consumption rate, malaria prevalence, efficacy and side effects and body organs physiologic status. Despite the 
presence of drug resistance to chloroquine and fansidar, the two drugs are still consumed due to the availability 
and low costs. The new drugs, Amalar and Cotecxin, are alternative therapy for chloroquine and fansidar but are 
rather expensive though available in the big urban cities. However, the physiologic consequence i.e. negative 
effects of both the new and the old drugs seem not to attract much comment like the clinical and 
parasitotological success or failure particularly with the new drugs. The implications are many especially with 
the high rate of antimalaria consumption the prevalence of malaria and tendency of high organs toxicity. Such 
characteristics may be the true situation of malaria mortality and morbidity and the resultant aggravation of 
future death tolls presumed to be caused by malaria but rather due to pharmacologic neglect and physiologic 
oversight in the disease.  
 
MATERIALS AND METHODS 
 Thirty (30) albino wistar rats of average weight 0.80kg – 1.41kg were used for the study. The animals 
were obtained from the stock in the Faculty of Pharmacy animal house University of Uyo and maintained daily 
with pellets food and water. The animals were of good health when obtained. Consent for use was not obtained 
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due to the absence of the animal right where the study was done. But the animals were not tortured. Six animals 
were placed in each drug group including control. 
 
DRUGS ADMINISTRATION 
 The antimalaria drugs; amalar, fansidar, chloroquine and cotecxin were purchased from a registered 
pharmacy shop. The drugs were administered based on the weight of the animal derived from the average weight 
of man; 70kg, according to the methods of Bertram, 2004 and Robert et al. 1979. The drugs were administered 
orally using canula by-passing the esophagus and delivered into the stomach based also on the curative and 
preventive dosages of the chloroquine, cotecxin, fansidar and amalar respectively, Jimmy et al., 2007. The 
effects of the drugs were monitored for the period of 28 days adopted from WHO (1982) model for antimalaria 
efficacy monitory. However, malaria parasites were not given to the animals in this study. 
 
HISTOLOGY: At the end of 28 days, the animals were anaesthetized with chloroform and the spleen were 
removed and processed according to the methods of druby and Wallington, 1967. Photomicrography of the 
sectioned tissues were made and interpreted for results. 
 
RESULTS 
 The investigation has shown marked effects of chloroquine, fansidar and cotecxin, while amalar drug 
demonstrated mild effect on the spleen. While chloroquine degenerated the splenic whites pulp and widen the 
interstitial space of the spleen (plate 1) clumping of periarteriolar lymphoid cells also in the white pulp was 
observed with fansidar (plate 2). However, cotecxin caused the degeneration of periarteriolar lymphoid sheaths, 
plate 3. But amalar also caused mild dilation of sinusoidal dilation in the red pulp of the spleen plate 4. But, the 




Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 






 The investigation has revealed significant physiologic observations particularly with specific effects of 
different antimalarials. The chloroquine specifically affected the white pulp causing the degeneration and 
widening of the interstitial space. The degeneration of the pulp indicates cells destruction of this vital organ and 
the widened interstitial space implies the abnormal expansion of such space for massive exudation of fluid into 
the interstitial space. The degeneration could also evolve into erosion and the tendency for the occlusion of the 
arterioles. The sum total effect of chloroquine action on the spleen is a disorder of it leading to spleen 
enlargement, splenomesgaly (Berkow et al 2001). Splenomegaly is a tropical syndrome in malaria disease 
observed in West Africa referred to as tropical syndrome, Bryceson et al. 1983. The characteristics of 
splenomegaly otherwise called the big spleen include spleen of at least 10cm, chronic malaria exposure, raise 
immunoglbulm (1g)m levels, hepatic sinusoidal lymphocytosis. In our study, it means the 1gm levels may have 
been raised though not measured. And increase immune levels also means increase lymphoproliferation which 
may be of the B cells origin which may result in Leukaemia, Fakunle, 1979. 
 The hepatic sinusoidal lympohocytosis implies the linkage effect of the spleen with the liver which may 
result in Jaundice, Guyton 2006. In our study, the induced effects of splenomegaly with chloroquine are 
correlated with that of malaria disease. It means that taking chloroquine in malaria infection may induced double 
negative effects in the spleen and will impair physiologic function. This same effect was observed with fansidar 
though fansidar caused the clumping of periateriolar lymphoid of the same white spleen pulp but the end result is 
still splenomegaly, and the resultant impairment of the spleen. Most striking was the effect of cotecxin; a 
dihydroartemisinin which is supposed to be an alternative drug for the chloroquine and fansidar. Cotecxin caused 
the degeneration of periarteriolar lymphoid sheath. Such effect will lead to necrosis of the cells of the white pulp 
such deformation of the spleen pulp will also attract mononuclear and polymorphonuclear infiltrations. These 
proliferations are the characteristics of splenomegaly. Importantly, the effect of the white pulp degeneration will 
eventually make the spleen to be very delicate which may result in splenic rupture. Such effects pronounce a 
deadly signal for a new drug like cotecxin. In a situation of increase malaria attacks as experienced in the 
tropical West Africa, then splenic rupture would be a significant medical diagnosis for those on cotecxin and 
splenomengaly for those on chloroquine and fansidar. So where lies the safety of treatment therapy in malaria? 
Amalar has it effect as it causes sinusoidal dilation of the red pulp though the effect was mild. There is therefore 
urgent need to reverse the trend of pharmacologic preparations because it appears the drug maiming on the 
organs is gradually over weighing the effects of the malaria disease and the mortality would also surpass that of 
the disease. This is why the pathophysiology of malaria disease should be topical in the research of 
pharmacologic potent drugs in the malaria models and therapeutic application. 
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